Medicus Pharma MDCX
NASDAQ MDCX
$0.27 0.00 (-0.15%)
At close: Aug 21, 2026 · 4:00 PM EDT

Medicus Pharma (MDCX) Cash from Operations (2024 - 2025)

Medicus Pharma's (MDCX) quarterly Cash from Operations came in at 6609115.0 in Q4 2025, down 107.08% YoY from 93328794.6 in Q4 2024, and up 2.2% on a QoQ basis from 6757829.0 in Q3 2025.

Medicus Pharma (MDCX) Cash from Operations (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has 2 years of Cash from Operations data on file, last reported at 6609115.0 in Q4 2025.

  • Quarterly Cash from Operations fell 107.08% year-over-year to 6609115.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 22776769.0 (down 122.27% YoY) and the FY2025 annual result came in at 22776769.0, down 122.27% from the prior year.
  • Cash from Operations improved to 6609115.0 in Q4 2025, from 6757829.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1176933.0 in Q1 2024 to a low of 6757829.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 8.62 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 3.44 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 3.57 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 835.00 Mn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Medicus Pharma 14.88 Mn -298,205.43 - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.61 Mn
Dec 31, 2025 -6.61 Mn
Sep 30, 2025 -6.76 Mn
Sep 30, 2025 -6.76 Mn
Jun 30, 2025 -5.47 Mn
Jun 30, 2025 -5.47 Mn
Mar 31, 2025 -3.94 Mn
Mar 31, 2025 -3.94 Mn
Dec 31, 2024 -3.19 Mn
Dec 31, 2024 -3.19 Mn
Sep 30, 2024 -3.10 Mn
Sep 30, 2024 -3.10 Mn
Jun 30, 2024 -2.78 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 -1.18 Mn
Mar 31, 2024 -1.18 Mn